About Vermedx®
The American health care system is poorly equipped to effectively and cost-efficiently manage chronic disease in general, and diabetes in particular. With 40 million Americans affected by diabetes and related costs exceeding $100 billion annually, established treatment practices are simply not good enough.
Vermedx programs embody the Chronic Care Model (CCM). This widely embraced approach to improving health outcomes emphasizes enabling provider teams to be prepared and proactive, and to interact regularly and effectively with well informed patients. It directly counteracts a leading factor in the current problem set: clinical inertia.
Clinical inertia translates to providers and patients allowing important treatment targets and process milestones to be ignored---not willfully, but due to a lack of access to critical information at critical times, and lack of the means to distribute that information to those needing to act upon it.
The human costs of diabetes are staggering. Unmet diabetes treatment targets result in dire complications including stroke, cardiovascular disease, renal failure, blindness, and amputations.
Quality Improvement is achieved by VDIS because:
- The VDIS technology is easy to access and to use for both providers and patients. The system’s cost per patient is negligible compared to the cost of sub-optimally treated populations.
- The system requires neither changes to provider process routines, nor significant time commitments for office staff to learn and use.
The VDIS system is HIPAA compliant. It operates effectively in low-tech (fax-capable only) office environments, as well as with leading electronic communications platforms such as Electronic Medical Records (EMR’s) and Electronic Health Records (EHR’s).
Please direct all inquiries to:
David L. Potter, Chief Marketing Officer
(401) 331-4941 or